Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3R2 | O00459 | 13/20 | 0.42 |
| ▸ | PIK3CD | O00329 | 15/20 | 0.39 |
| ▸ | PIK3CG | P48736 | 7/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 4/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.38 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14726987 | 0.89 | PIK3R2 (0.51) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL14730063 | 0.86 | PIK3CD (0.36) | PIK3CDPIK3R1 | |
| SCHEMBL14757801 | 0.80 | PIK3CD (0.42) | PIK3R2PIK3CDPIK3CG | |
| SCHEMBL17235024 | 0.77 | PIK3R2 (0.54) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL17235220 | 0.77 | PIK3R2 (0.54) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL17235006 | 0.77 | PIK3R2 (0.54) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL14726975 | 0.75 | PIK3CD (0.45) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL1695322 | 0.74 | PIK3CD (0.46) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL10146933 | 0.74 | PIK3CD (0.46) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA | |
| SCHEMBL4569333 | 0.73 | BTK (0.41) | PIK3R2PIK3CDPIK3CGPIK3CBPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130053362-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | INTELLKINE, LLC (US) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053362-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | AKT3, PIK3CA, AKT1 | PIK3R2 91/4885PIK3CD 5/4885PIK3CG 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.